>아시아 태평양 정맥 질환 치료 시장, 제품 유형별(경화 요법 주사, 절제 장치, 정맥 폐쇄 제품, 정맥 스텐트, 약물 및 기타), 질병 유형(심부 정맥 혈전증(DVT), 만성 정맥 기능 부전(CVI), 폐색전증, 표재성 혈전정맥염, 정맥류 및 기타), 치료 유형(경화 요법, 고주파 절제 요법, 레이저 치료, 외래 정맥 절제술, 정맥 결찰 및 박리, 혈관 성형술 또는 스텐트 삽입, 수술, 압박 요법, 정맥 작용 약물, 하대정맥 필터 및 기타 요법), 최종 사용자(병원, 진료소, 외래 수술 센터 및 기타), 유통 채널(직접 입찰, 소매 판매 및 기타) - 업계 동향 및 2030년까지의 예측.
아시아 태평양 정맥 질환 치료 시장 분석 및 통찰력
정맥 질환에는 다리, 팔, 뇌, 폐 또는 신장, 비장, 간과 같은 내부 장기의 혈전, 심부정맥혈전증, 만성 정맥 기능 부전, 정맥류 및 정맥, 정맥 궤양이 포함됩니다. 이 질환에 대한 치료에는 약물 요법, 내인성 레이저 절제술 또는 고주파 절제술(RFA), 경화 요법 및 수술이 포함됩니다.
Data Bridge Market Research는 아시아 태평양 정맥 질환 치료 시장이 2030년까지 2,118.93백만 달러에 도달할 것으로 예상하며, 예측 기간 동안 CAGR은 8.4%라고 분석했습니다. 이 시장 보고서는 또한 가격 분석, 특허 분석 및 기술 발전에 대한 심층적인 내용을 다룹니다.
보고서 메트릭 |
세부 |
예측 기간 |
2023년부터 2030년까지 |
기준 연도 |
2022 |
역사적 연도 |
2021 (2020-1015까지 사용자 정의 가능) |
양적 단위 |
수익은 백만 달러, 가격은 미화로 표시 |
다루는 세그먼트 |
제품 유형별(경화요법 주사, 절제 장치, 정맥 폐쇄 제품, 정맥 스텐트, 약물 및 기타), 질병 유형별(심부정맥혈전증(DVT), 만성정맥부전(CVI), 폐색전증, 표재성 혈전정맥염, 정맥류 및 기타), 치료 유형별(경화요법, 고주파 절제 요법, 레이저 치료, 외래 정맥절제술, 정맥 결찰 및 스트리핑, 혈관성형술 또는 스텐트 삽입, 수술, 압박 요법, 정맥 작용 약물, 하대정맥 필터 및 기타 요법), 최종 사용자별(병원, 진료소, 외래 수술 센터 및 기타), 유통 채널별(직접 입찰, 소매 판매 및 기타) |
적용 국가 |
중국, 인도, 일본, 인도네시아, 필리핀, 태국, 호주, 말레이시아, 한국, 싱가포르, 기타 아시아 태평양 지역 |
시장 참여자 포함 |
Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex corporation, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips NV, Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems, Bolitec Laser 등이 있습니다. |
아시아 태평양 정맥 질환 치료 시장 정의
심장마비와 뇌졸중은 일반적으로 급성 사건이며, 주로 심장이나 뇌로의 혈류를 막는 막힘으로 인해 발생합니다. 가장 흔한 원인은 심장이나 뇌에 혈액을 공급하는 혈관의 내벽에 지방이 축적되는 것입니다. 뇌졸중은 뇌의 혈관에서 출혈이나 혈전으로 인해 발생할 수 있습니다.
혈관 스텐트의 기술적 발전, 최소 침습적 시술에 대한 수요 증가, 노령 인구의 증가가 아시아 태평양 시장을 주도하고 있습니다. 게다가, 기업들은 정맥 질환 치료를 위한 최상의 서비스를 제공하기 위해 제품 포트폴리오를 확장하고 있습니다. 절제 장치와 같은 의료 기기는 치료 목적으로 비정상적인 신체 조직을 제거하거나 절제하는 최소 침습적 시술에 사용됩니다. 이러한 시스템은 무선 주파수, 에너지, 극한의 추위 또는 레이저로 생성된 열을 사용하여 작은 화상을 유발합니다. 제품 적용 확장을 위한 로봇 기술 채택 증가, 환자 안전과 시술 효율성을 개선하기 위한 절제 장치에 최첨단 기술을 통합하여 시장을 주도할 것으로 예상됩니다.
아시아 태평양 정맥 질환 치료 시장 역학
이 섹션에서는 시장 동인, 이점, 기회, 제약 및 과제를 이해하는 것을 다룹니다. 이 모든 내용은 아래에서 자세히 설명합니다.
운전자
- 정맥 질환의 증가 발생률
정맥 질환은 신체의 정맥을 손상시키는 상태입니다. 손상된 혈관 벽은 순환계가 작동하지 못하게 하여 근육이 이완될 때 혈액이 고여 역류(뒤로)됩니다. 이로 인해 정맥에 비정상적으로 높은 압력이 쌓입니다. 이러한 쌓임으로 인해 정맥이 조여지고 꼬이고, 붓기가 증가하고, 판막 무능력이 증가하고, 혈류가 느려지고, 혈전이 생길 수 있습니다. 마지막으로, 이러한 상태는 정맥 질환으로 알려진 다양한 질병으로 이어질 수 있습니다.
노화, 비만, 고혈압(고혈압) 또는 정맥 질환의 가족력과 같은 다양한 위험 요인으로 인해 정맥 질환 환자는 전 세계적으로 증가하고 있으며 중요한 사회 경제적 문제가 되고 있습니다. 따라서 정맥 질환 환자 수가 증가함에 따라 아시아 태평양 정맥 질환 치료 시장의 원동력으로 작용하는 정맥 질환 치료에 대한 수요가 증가합니다.
- 생활습관의 급격한 변화로 비만으로 인한 정맥질환 발생 증가
흡연, 건강에 해로운 식습관, 신체 활동 부족 등의 생활 습관 변화는 만성 질환, 특히 심장병, 뇌졸중, 당뇨, 비만, 대사 증후군의 발병으로 이어지며, 결국 정맥 질환으로 이어질 수 있습니다.
신체 활동은 필수적이며 많은 질환이 앉아서 지내는 생활 방식의 직접적인 결과입니다. 앉아서 지내는 생활 방식은 체중 증가, 피로감 증가, 만성 질환(심혈관 및 정맥 질환 포함)으로 이어질 수 있는 설명할 수 없는 통증과 통증을 유발할 수 있으며, 중증, 중증 또는 심지어 생명을 위협할 수 있습니다.
ScienceDirect 기사에 따르면, 정맥 질환은 비만하지 않은 그룹보다 비만 사지에서 임상적으로 더 심각했습니다. 따라서 건강에 해로운 생활 방식을 채택하는 것이 증가함에 따라 정맥 질환이 증가하는 비만 인구가 빠르게 증가하고 있습니다. 따라서 생활 방식의 빠른 변화는 비만으로 이어져 정맥 질환이 발생하여 정맥 질환 치료에 대한 수요가 증가하고 아시아 태평양 정맥 질환 치료 시장의 원동력이 됩니다.
제지
- 숙련되고 인증된 전문가가 부족합니다
숙련되고 인증된 전문가에 대한 요구는 정맥 질환 치료 시장에 큰 제약입니다. 유럽에서 정맥 질환 사례가 증가함에 따라 정맥 질환 치료에 대한 수요가 증가했지만 의료 센터에 있는 숙련된 전문가의 수가 적어 시장 성장을 방해하고 있습니다.
만성 정맥 질환(CVD)은 종종 의료 전문가들이 문제의 범위와 영향을 이해하지 못하고, 1차 및 2차 정맥 질환의 다양한 증상을 완전히 인식하지 못하기 때문에 간과됩니다. 심혈관 질환의 중요성은 환자 수와 더 심각한 증상의 사회경제적 영향과 관련이 있습니다.
기회
- 정맥 질환에 대한 인식 증가
정맥 문제를 치료하는 데는 약물 치료와 생활 습관의 변화가 모두 사용될 수 있습니다. 정맥은 약물, 운동, 압박 스타킹으로 이점을 얻을 수 있지만, 가끔 정맥 문제는 정맥의 건강과 성능을 회복하기 위해 보다 철저한 치료가 필요합니다. 치료 과정은 정맥 질환의 종류와 심각도에 따라 결정됩니다. 혈관 질환 환자는 지난 수십 년 동안 극적으로 증가했으며, 당뇨병은 가장 심각한 위험 요인으로 작용했습니다. 다른 건강 문제와 달리 혈관 질환과 혈관 수술은 인구의 약 80%에게 알려지지 않았습니다. 사람들의 특정 질병에 대한 태도와 행동은 건강 인식이 높아짐에 따라 크게 바뀔 수 있습니다.
다양한 사회, 정부 기관 및 기타 기관에서 여러 가지 인식 프로그램을 실시하고 있습니다. 이러한 이니셔티브를 통해 사람들은 건강에 대한 인식을 높이고 더 나은 치료와 예방을 위해 조기 진단을 받을 수 있습니다. 이러한 이유로 정맥 질환에 대한 인식이 높아지면 아시아 태평양 정맥 질환 치료 시장 수요가 증가할 수 있는 기회가 될 것으로 예상됩니다.
도전
- 정맥 질환 치료와 관련된 높은 비용
미국에서만 2,500만 명 이상이 만성 정맥 기능 부전(CVI)을 앓고 있으며, 600만 명 이상이 진행성 정맥 질환을 앓고 있습니다. 미국의 의료 시스템은 CVI의 높은 발병률과 증가하는 의료비로 인해 재정적으로 큰 부담을 받고 있습니다. 수많은 광범위한 건강 문제는 정맥 순환이 좋지 않아 발생합니다. 다리 통증, 부종, 무거움은 만성 정맥 질환(CVD)의 초기 징후 중 일부이며, 하루 종일 나타나거나 저녁에 더 심해질 수 있습니다. 환자는 정맥류가 있거나 없이 발생할 수 있는 증상과 미용적 정맥류 제거를 위해 초기 치료를 자주 찾습니다. CVD의 두 가지 주요 위험 요인은 나이 증가와 높은 체중입니다.
COVID-19 이후 아시아 태평양 정맥 질환 치료 시장에 미치는 영향
팬데믹은 제조업체와 사용자에게 모두 부정적인 영향을 미쳤습니다. 정맥류 시술은 긴급하지 않기 때문에 시술 건수가 급격히 감소했습니다. 여행 제한으로 인해 정맥류 치료를 위한 수술이나 시술이 감소한 것도 제조업체의 판매에 영향을 미쳤습니다.
제조업체들은 COVID-19 이후 회복하기 위해 다양한 전략적 결정을 내리고 있습니다. 업체들은 반려동물 사료 맛과 성분 시장에 관련된 기술과 테스트 결과를 개선하기 위해 여러 R&D 활동과 제품 출시 및 전략적 파트너십을 진행하고 있습니다.
최근 개발 사항
- 2022년 7월, 아시아 태평양 의료 기술 회사인 Smith+Nephew는 상처 치료의 실무적 변화를 줄이는 데 도움이 되는 Clinical Support App을 출시했습니다. WOUND COMPASS Clinical Support App은 의료 전문가를 위한 포괄적인 디지털 지원 도구로, 상처 평가 및 의사 결정을 지원하여 실무적 변화를 줄이는 데 도움이 됩니다. 이를 통해 회사는 의료 고객을 유치하고 제품 포트폴리오를 확장하는 데 도움이 되었습니다.
- 2022년 4월, Carl Zeiss Meditec은 솔루션 제공업체로서의 입지를 더욱 강화하기 위해 수술 도구 제조업체 두 곳(Kogent Surgical, LLC 및 Katalyst Surgical, LLC)을 인수한다고 발표했습니다. 이를 통해 회사는 사업을 확장하는 데 도움이 되었습니다.
아시아 태평양 정맥 질환 치료 시장 범위
아시아 태평양 정맥 질환 치료 시장은 제품 유형, 질병 유형, 치료 유형, 최종 사용자 및 유통 채널로 세분화됩니다. 세그먼트 간의 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
제품 유형별 아시아 태평양 정맥 질환 치료 시장
- 절제 장치
- 정맥 스텐트
- 정맥 폐쇄 제품
- 경화요법 주사
- 약물
- 기타
제품 유형을 기준으로 볼 때 아시아 태평양 정맥 질환 치료 시장은 절제 장치, 정맥 스텐트, 정맥 폐쇄 제품, 경화 요법 주사, 약물 및 기타로 구분됩니다.
아시아 태평양 정맥 질환 치료 시장, 질병 유형별
- 심부정맥혈전증(DVT)
- 만성정맥부전(CVI)
- 폐색전증
- 표재성 혈전정맥염
- 정맥류
- 기타
질병 유형을 기준으로 볼 때 아시아 태평양 정맥 질환 치료 시장은 심부정맥혈전증(DVT), 만성정맥부전(CVI), 폐색전증, 표재성 혈전성 정맥염, 정맥류 등으로 구분됩니다.
치료 유형별 아시아 태평양 정맥 질환 치료 시장
- 압축 요법
- 정맥 활성 약물
- 수술
- 경화요법
- 혈관성형술 또는 스텐팅
- 정맥 결찰 및 제거
- 베나 카바 필터
- 외래 정맥 절제술
- 고주파 절제 치료
- 레이저 치료
- 기타 치료법
아시아 태평양 정맥 질환 치료 시장은 치료 유형을 기준으로 압박 요법, 정맥 활성 약물 치료, 수술, 경화요법, 혈관성형술 또는 스텐트 삽입, 정맥 절단 및 제거, 하대정맥 필터, 외래 정맥절제술, 고주파 소거 요법, 레이저 치료 및 기타 요법으로 구분됩니다.
최종 사용자별 아시아 태평양 정맥 질환 치료 시장
- 병원
- 클리닉
- 외래 수술 센터
- 기타
아시아 태평양 정맥 질환 치료 시장은 최종 사용자를 기준으로 병원, 진료소, 외래 수술 센터 및 기타로 구분됩니다.
아시아 태평양 정맥 질환 치료 시장, 유통 채널별
- 직접 입찰
- 소매 판매
- 기타
아시아 태평양 정맥 질환 치료 시장은 유통 채널을 기준으로 직접 입찰, 소매 판매 및 기타로 구분됩니다.
아시아 태평양 정맥 질환 치료 시장 지역 분석/통찰력
아시아 태평양 정맥 질환 치료 시장을 분석하고, 제품 유형, 질병 유형, 치료 유형, 최종 사용자 및 유통 채널에 대한 시장 규모 정보를 제공합니다.
중국은 인구 중 정맥 질환의 유병률이 증가하면서 아시아 태평양 지역을 주도하고 있습니다.
보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 아시아 태평양 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.
경쟁 환경 및 아시아 태평양 정맥 질환 치료 시장 점유율 분석
아시아 태평양 정맥 질환 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선입니다. 위에 제공된 데이터 포인트는 아시아 태평양 정맥 질환 치료 시장에 대한 회사의 초점과만 관련이 있습니다.
아시아 태평양 정맥 질환 치료 시장의 주요 기업으로는 Abbott, Imricor, Baylis Medical Company, Inc., Theraclion, Sonablate, plusmedica.de, Boston Scientific Corporation, Olympus Corporation, Smith + Nephew, Cook, Scitech, Carl Zeiss Meditec AG, Teleflex corporate, Alma Lasers, BD, B.Braun SE, Medtronic, Stryker, Koninklijke Philips NV, Varian Medical Systems, Candela Corporation, Teromo corporation, Angiodynamics, optimed Medizinische Instrumente GmbH, Merit Medical Systems, Bolitec Laser 등이 있습니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 INSTRUMENT BASED LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES
5 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, INDUSTRY INSIGHTS
6 EPIDEMIOLOGY
7 REGULATORY FRAMEWORK
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 RISING INCIDENCES OF VENOUS DISEASES
8.1.2 RAPID CHANGES IN LIFESTYLE LEAD TO OBESITY RESULTING IN VENOUS DISEASES
8.1.3 INCREASE IN THE GERIATRIC POPULATION
8.1.4 TECHNOLOGICALLY ADVANCEMENT IN THE TREATMENT OF VENOUS DISEASES
8.2 RESTRAINTS
8.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
8.2.2 INADEQUATE REIMBURSEMENT COVERAGE
8.3 OPPORTUNITIES
8.3.1 RISING AWARENESS TOWARDS VENOUS DISORDERS
8.3.2 NEED FOR PROPER DIAGNOSIS AND TREATMENT OF VENOUS DISEASES
8.3.3 GROWING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES
8.3.4 OCCUPATIONAL LIFESTYLE INCREASES THE NEED FOR VENOUS DISEASE TREATMENT
8.4 CHALLENGES
8.4.1 HIGH COST ASSOCIATED WITH VENOUS DISEASE TREATMENT
8.4.2 SIDE EFFECTS AND RISK ASSOCIATED WITH DIFFERENT TREATMENT MODES
9 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE
9.1 OVERVIEW
9.2 SCLEROTHERAPY INJECTION
9.2.1 SCLEROTHERAPY, BY TYPE
9.2.1.1 INTRAVENOUS
9.2.1.2 INTRADERMAL
9.2.1.3 SUBCUTANEOUS
9.2.2 SUBCUTANEOUS, BY APPLICATION
9.2.2.1 MALFORMED LYMPHED VESSELS
9.2.2.2 HEMORRHOIDS
9.2.2.3 HYDROCELES
9.2.2.4 OTHERS
9.3 ABLATION DEVICES
9.3.1 THERMAL ABLATION
9.3.1.1 RADIOFREQUENCY
9.3.1.1.1 CATHETER MANIPULATION SYSTEMS
9.3.1.1.2 TEMPERATURE CONTROLLED
9.3.1.1.3 FLUID COOLED
9.3.1.2 LIGHT
9.3.1.2.1 EXCIMER LASERS
9.3.1.2.2 COLD LASERS
9.3.1.3 ULTRASOUND
9.3.1.3.1 HIGH INTENSITY FOCUSED ULTRASOUND (HIFU)
9.3.1.3.2 SHOCK WAVE LITHOTRIPSY
9.3.1.3.3 MAGNETIC RESONANCE IMAGING GUIDED FOCUSED ULTRASOUND (MRI-FUS)
9.3.1.3.4 ULTRASONIC SURGICAL SYSTEMS
9.3.1.4 RADIATION
9.3.1.4.1 STEREOTACTIC BODY RADIATION THERAPY
9.3.1.4.2 INTENSITY-MODULATED RADIATION THERAPY
9.3.1.4.3 STEREOTACTIC RADIOTHERAPY & RADIOSURGERY
9.3.1.4.4 IMAGE GUIDED RADIATION THERAPY
9.3.1.4.5 INTRAVASCULAR BRACHYTHERAPY
9.3.1.4.6 PROTON BEAM THERAPY
9.3.1.5 ELECTRICAL
9.3.1.5.1 ELECTRICAL ABLATORS
9.3.1.5.2 ELECTRONIC BRACHYTHERAPY
9.3.1.6 MICROWAVE
9.3.1.7 HYDROTHERMAL
9.3.2 NON-THERMAL ABLATION
9.3.2.1 CRYOABLATION
9.3.2.1.1 EPIDERMAL AND SUBCUTANEOUS CRYOABLATION DEVICES
9.3.2.1.2 CRYOGEN SPRAY PROBE
9.3.2.1.3 TISSUE CONTACT PROBE
9.3.2.2 HYDROMECHANICAL ABLATION
9.4 VENOUS CLOSURE PRODUCTS
9.4.1 VENOUS CLOSURE PRODUCTS, BY PROCEDURE
9.4.1.1 INTERVENTIONAL CARDIOLOGY
9.4.1.2 INTERVENTIONAL RADIOLOGY
9.4.2 VENOUS CLOSURE PRODUCTS, BY TECHNOLOGY
9.4.2.1 FEMORAL ACCESS TECHNIQUE
9.4.2.2 RADIAL ACCESS TECHNIQUE
9.5 VENOUS STENTS
9.5.1 VENOUS STENTS, BY TECHNOLOGY
9.5.1.1 WALLSTENT TECHNOLOGY
9.5.1.2 ILIAC VEIN STENT TECHNOLOGY
9.5.2 VENOUS STENTS, BY APPLICATION
9.5.2.1 LEG
9.5.2.2 CHEST
9.5.2.3 ABDOMEN
9.5.2.4 OTHERS
9.6 MEDICATION
9.7 OTHERS
10 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE
10.1 OVERVIEW
10.2 VARICOSE VEINS
10.3 DEEP VEIN THROMBOSIS (DVT)
10.4 PULMONARY EMBOLISM
10.5 CHRONIC VENOUS INSUFFICIENCY (CVI)
10.6 SUPERFICIAL THROMBOPHLEBITIS
10.7 OTHERS
11 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE
11.1 OVERVIEW
11.2 SCLEROTHERAPY
11.3 RADIOFREQUENCY ABLATION THERAPY
11.4 LASER TREATMENT
11.5 AMBULATORY PHLEBECTOMY
11.6 VEIN LIGATION AND STRIPPING
11.7 ANGIOPLASTY OR STENTING
11.8 SURGERIES
11.9 COMPRESSION THERAPY
11.1 VEINACTIVE MEDICATION
11.11 VENA CAVA FILTER
11.12 OTHER THERAPIES
12 ASIA-PACIFIC VENOUS TREATMENT DISEASES MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITALS
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 OTHERS
13 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
13.4 OTHERS
14 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY REGION
14.1 ASIA-PACIFIC
14.1.1 CHINA
14.1.2 JAPAN
14.1.3 INDIA
14.1.4 AUSTRALIA
14.1.5 INDONESIA
14.1.6 SINGAPORE
14.1.7 MALAYSIA
14.1.8 PHILIPPINES
14.1.9 SOUTH KOREA
14.1.10 THAILAND
14.1.11 REST OF ASIA-PACIFIC
15 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 MEDTRONIC
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 COMPANY SHARE ANALYSIS
17.1.4 PRODUCT PORTFOLIO
17.1.5 RECENT DEVELOPMENTS
17.2 BOSTON SCIENTIFIC CORPORATION
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 COMPANY SHARE ANALYSIS
17.2.4 PRODUCT PORTFOLIO
17.2.5 RECENT DEVELOPMENTS
17.3 VARIAN MEDICAL SYSTEMS, INC.
17.3.1 COMPANY SNAPSHOT
17.3.2 COMPANY SHARE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 STRYKER
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 COMPANY SHARE ANALYSIS
17.4.4 PRODUCT PORTFOLIO
17.4.5 RECENT DEVELOPMENT
17.5 KONINKLIJKE PHILIPS N.V.
17.5.1 COMPANY SNAPSHOT
17.5.2 REVENUE ANALYSIS
17.5.3 COMPANY SHARE ANALYSIS
17.5.4 PRODUCT PORTFOLIO
17.5.5 RECENT DEVELOPMENT
17.6 ABBOTT
17.6.1 COMPANY SNAPSHOT
17.6.2 REVENUE ANALYSIS
17.6.3 PRODUCT PORTFOLIO
17.6.4 RECENT DEVELOPMENT
17.7 ALMA LASERS
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENT
17.8 ANGIODYNAMICS
17.8.1 COMPANY SNAPSHOT
17.8.2 REVENUE ANALYSIS
17.8.3 PRODUCT PORTFOLIO
17.8.4 RECENT DEVELOPMENT
17.9 B.BRAUN MELSUNGEN AG
17.9.1 COMPANY SNAPSHOT
17.9.2 REVENUE ANALYSIS
17.9.3 PRODUCT PORTFOLIO
17.9.4 RECENT DEVELOPMENTS
17.1 BAYLIS MEDICAL COMPANY, INC
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 BD
17.11.1 COMPANY SNAPSHOT
17.11.2 REVENUE ANALYSIS
17.11.3 PRODUCT PORTFOLIO
17.11.4 RECENT DEVELOPMENT
17.12 CANDELA MEDICAL
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.13 CARL ZEISS MEDITEC AG
17.13.1 COMPANYSNAPSHOT
17.13.2 REVENUE ANALYSIS
17.13.3 PRODUCT PORTFOLIO
17.13.4 RECENT DEVELOPMENT
17.14 COOK
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENTS
17.15 IMRICOR
17.15.1 COMPANY SNAPSHOT
17.15.2 REVENUE ANALYSIS
17.15.3 PRODUCT PORTFOLIO
17.15.4 RECENT DEVELOPMENT
17.16 OLYMPUS CORPORATION
17.16.1 COMPANY SNAPSHOT
17.16.2 REVENUE ANALYSIS
17.16.3 PRODUCT PORTFOILIO
17.16.4 RECENT DEVELOPMENT
17.17 OPTIMED MEDIZINISCHE INSTRUMENTE GMBH
17.17.1 COMPANY SNAPSHOT
17.17.2 PRODUCT PORTFOLIO
17.17.3 RECENT DEVELOPMENTS
17.18 PLUSMEDICA.DE
17.18.1 COMPANY SNAPSHOT
17.18.2 PRODUCT PORTFOLIO
17.18.3 RECENT DEVELOPMENT
17.19 SCITECH
17.19.1 COMPANY SNAPSHOT
17.19.2 PRODUCT PORTFOLIO
17.19.3 RECENT DEVELOPMENTS
17.2 SMITH + NEPHEW
17.20.1 COMPANY SNAPSHOT
17.20.2 REVENUE ANALYSIS
17.20.3 PRODUCT PORTFOLIO
17.20.4 RECENT DEVELOPMENT
17.21 SONABLATE
17.21.1 COMPANY SNAPSHOT
17.21.2 PRODUCT PORTFOLIO
17.21.3 RECENT DEVELOPMENT
17.22 THERACLION
17.22.1 COMPANY SNAPSHOT
17.22.2 REVENUE ANALYSIS
17.22.3 PRODUCT PORTFOLIO
17.22.4 RECENT DEVELOPMENT
17.23 TELEFLEX INCORPORATED
17.23.1 COMPANY SNAPSHOT
17.23.2 REVENUE ANALYSIS
17.23.3 PRODUCT PORTFOLIO
17.23.4 RECENT DEVELOPMENTS
17.24 TERUMO CORPORATION
17.24.1 COMPANY SNAPSHOT
17.24.2 REVENUE ANALYSIS
17.24.3 PRODUCT PORTFOLIO
17.24.4 RECENT DEVELOPMENTS
18 QUESTIONNAIRE
19 RELATED REPORTS
표 목록
TABLE 1 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 2 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 5 ASIA-PACIFIC ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 6 ASIA-PACIFIC ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 7 ASIA-PACIFIC THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 ASIA-PACIFIC RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 9 ASIA-PACIFIC LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 10 ASIA-PACIFIC ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA-PACIFIC RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 12 ASIA-PACIFIC ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 13 ASIA-PACIFIC NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 14 ASIA-PACIFIC CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 16 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 17 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 18 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 19 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 20 ASIA-PACIFIC ILIAC VEIN STENT TECHNOLOGY IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 21 ASIA-PACIFIC MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 23 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA-PACIFIC VARICOSE VEINS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 ASIA-PACIFIC DEEP VEIN THROMBOSIS (DVT) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 26 ASIA-PACIFIC PULMONARY EMBOLISM IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 ASIA-PACIFIC CHRONIC VENOUS INSUFFICIENCY (CVI) IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC SUPERFICIAL THROMBOPHLEBITIS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC SCELEROTHERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC RADIOFREQUENCY ABLATION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 ASIA-PACIFIC LASER TREATMENT IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 ASIA-PACIFIC AMBULATORY PHELEBECTOMY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 ASIA-PACIFIC VEIN LIGATION AND STRIPPING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 36 ASIA-PACIFIC ANGIOPLASTY OR STENTING IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 ASIA-PACIFIC SURGERIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 ASIA-PACIFIC COMPRESSION THERAPY IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 ASIA-PACIFIC VEINACTIVE MEDICATION IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 40 ASIA-PACIFIC VENA CAVA FILTER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 ASIA-PACIFIC OTHER THERAPIES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 43 ASIA-PACIFIC HOSPITALS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 ASIA-PACIFIC CLINICS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 47 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 48 ASIA-PACIFIC DIRECT TENDER IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 ASIA-PACIFIC RETAIL SALES IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 ASIA-PACIFIC OTHERS IN VENOUS DISEASES TREATMENT MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 ASIA-PACIFIC VENOUS DISEASE TREATMENT MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 52 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 53 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 ASIA-PACIFIC SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 ASIA-PACIFIC ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 56 ASIA-PACIFIC THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 57 ASIA-PACIFIC RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 58 ASIA-PACIFIC LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 59 ASIA-PACIFIC ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 60 ASIA-PACIFIC RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 61 ASIA-PACIFIC ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 62 ASIA-PACIFIC NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 63 ASIA-PACIFIC CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 64 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 65 ASIA-PACIFIC VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 66 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 67 ASIA-PACIFIC VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 69 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 70 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 71 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 72 CHINA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 73 CHINA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 74 CHINA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 75 CHINA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 76 CHINA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 77 CHINA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 78 CHINA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 79 CHINA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 80 CHINA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 81 CHINA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 82 CHINA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 83 CHINA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 CHINA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 85 CHINA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 86 CHINA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 87 CHINA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 CHINA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 89 CHINA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 90 CHINA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 91 CHINA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 92 JAPAN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 93 JAPAN SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 94 JAPAN SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 JAPAN ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 96 JAPAN THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 97 JAPAN RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 98 JAPAN LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 99 JAPAN ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 100 JAPAN RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 101 JAPAN ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 102 JAPAN NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 103 JAPAN CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 104 JAPAN VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 105 JAPAN VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 106 JAPAN VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 107 JAPAN VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 108 JAPAN VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 109 JAPAN VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 110 JAPAN VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 111 JAPAN VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 112 INDIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 INDIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 INDIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 115 INDIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 116 INDIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 117 INDIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 118 INDIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 119 INDIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 120 INDIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 121 INDIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 122 INDIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 123 INDIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 124 INDIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 125 INDIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 126 INDIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 127 INDIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 128 INDIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 129 INDIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 130 INDIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 INDIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 AUSTRALIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 134 AUSTRALIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 135 AUSTRALIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 AUSTRALIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 137 AUSTRALIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 AUSTRALIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 AUSTRALIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 AUSTRALIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 141 AUSTRALIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 AUSTRALIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 143 AUSTRALIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 AUSTRALIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 145 AUSTRALIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 146 AUSTRALIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 147 AUSTRALIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 148 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 149 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 150 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 151 AUSTRALIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 152 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 153 INDONESIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 INDONESIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 155 INDONESIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 156 INDONESIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 157 INDONESIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 158 INDONESIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 159 INDONESIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 160 INDONESIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 161 INDONESIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 162 INDONESIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 163 INDONESIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 164 INDONESIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 165 INDONESIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 166 INDONESIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 167 INDONESIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 169 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 170 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 171 INDONESIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 172 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 173 SINGAPORE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 174 SINGAPORE SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 176 SINGAPORE THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 177 SINGAPORE RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 178 SINGAPORE LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 179 SINGAPORE ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 180 SINGAPORE RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 181 SINGAPORE ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 182 SINGAPORE NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 183 SINGAPORE CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 184 SINGAPORE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 185 SINGAPORE VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 186 SINGAPORE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 187 SINGAPORE VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 188 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 189 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 190 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 191 SINGAPORE VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 192 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 193 MALAYSIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 194 MALAYSIA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 195 MALAYSIA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 MALAYSIA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 197 MALAYSIA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 MALAYSIA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 MALAYSIA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 200 MALAYSIA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 MALAYSIA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 MALAYSIA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 203 MALAYSIA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 MALAYSIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 205 MALAYSIA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 206 MALAYSIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 207 MALAYSIA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 208 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 209 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 210 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 211 MALAYSIA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 212 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 213 PHILIPPINES SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 214 PHILIPPINES SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 215 PHILIPPINES ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 216 PHILIPPINES THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 PHILIPPINES RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 PHILIPPINES LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 219 PHILIPPINES ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 PHILIPPINES RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 PHILIPPINES ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 222 PHILIPPINES NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 223 PHILIPPINES CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 224 PHILIPPINES VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 225 PHILIPPINES VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 226 PHILIPPINES VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 227 PHILIPPINES VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 229 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 230 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 231 PHILIPPINES VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 232 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 233 SOUTH KOREA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 234 SOUTH KOREA SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 SOUTH KOREA ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 236 SOUTH KOREA THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 237 SOUTH KOREA RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 238 SOUTH KOREA LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 239 SOUTH KOREA ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 240 SOUTH KOREA RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 241 SOUTH KOREA ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 242 SOUTH KOREA NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 243 SOUTH KOREA CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 244 SOUTH KOREA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 245 SOUTH KOREA VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 246 SOUTH KOREA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 247 SOUTH KOREA VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 248 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 249 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 250 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 251 SOUTH KOREA VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 252 THAILAND VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 THAILAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 254 THAILAND SCLEROTHERAPY INJECTION IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 255 THAILAND ABLATION DEVICES IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 256 THAILAND THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 257 THAILAND RADIOFREQUENCY IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 258 THAILAND LIGHT IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 THAILAND ULTRASOUND IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 260 THAILAND RADIATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 261 THAILAND ELECTRICAL IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 THAILAND NON-THERMAL ABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 263 THAILAND CRYOABLATION IN VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 264 THAILAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY PROCEDURE, 2021-2030 (USD MILLION)
TABLE 265 THAILAND VENOUS CLOSURE PRODUCTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 266 THAILAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 267 THAILAND VENOUS STENTS IN VENOUS DISEASES TREATMENT MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 268 THAILAND VENOUS DISEASES TREATMENT MARKET, BY DISEASE TYPE, 2021-2030 (USD MILLION)
TABLE 269 THAILAND VENOUS DISEASES TREATMENT MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 270 THAILAND VENOUS DISEASES TREATMENT MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 271 THAILAND VENOUS DISEASES TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 272 REST OF ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
그림 목록
FIGURE 1 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: ASIA-PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SEGMENTATION
FIGURE 11 GROWING AWARENESS ABOUT VENOUS DISEASES TREATMENTS AND INCREASING HEALTHCARE EXPENDITURE IS EXPECTED TO DRIVE THE GROWTH OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET FROM 2023 TO 2030
FIGURE 12 THE ABLATION DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET
FIGURE 14 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2022
FIGURE 15 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, 2023-2030 (USD MILLION)
FIGURE 16 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, CAGR (2023-2030)
FIGURE 17 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2022
FIGURE 19 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, 2023-2030 (USD MILLION)
FIGURE 20 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, CAGR (2023-2030)
FIGURE 21 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2022
FIGURE 23 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)
FIGURE 24 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, CAGR (2023-2030)
FIGURE 25 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, 2022
FIGURE 27 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: SNAPSHOT (2022)
FIGURE 35 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022)
FIGURE 36 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2023 & 2030)
FIGURE 37 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: BY COUNTRY (2022 & 2030)
FIGURE 38 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: PRODUCT TYPE (2023-2030)
FIGURE 39 ASIA-PACIFIC VENOUS DISEASES TREATMENT MARKET: COMPANY SHARE 2022 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.